An experimental treatment appears to delay Alzheimer’s symptoms in some people genetically destined to get the disease in their 40s or 50s, according to new findings from ongoing research now caught ...

The blood biomarker p-tau217 has "shown the most promise in detecting Alzheimer's in the brain," researchers of a new study say.

But here's why you likely won't be seeing it in your doctor's office anytime soon.

Researchers from the University of California San Diego have found that a novel blood-based biomarker can predict a woman's risk of developing dementia as many as 25 years before symptoms appear.

A team of Mayo Clinic scientists have created a way to estimate a person’s risk of developing memory and thinking problems long before symptoms of Alzheimer’s disease begin, potentially changing how ...